ESC 365 - Doctor Jochen Dutzmann

Speaker illustration

Doctor Jochen Dutzmann

University Hospital Halle (Saale), Halle (Germany)

Member of:

Heart Failure Association

Jochen Dutzmann gained his MD from the Justus Liebig University in Giessen, Germany in 2013. During his studies, he spent several months as a visiting student at The Children's Hospital of the University of Colorado in Denver, as a research fellow at the Cardiovascular Division of the Brigham and Women's Hospital/Harvard Medical School in Boston, USA as well as a MD student at the Dept. of Internal Medicine of the University Hospital Basel, Switzerland. He served as a clinical resident and fellow at the Dept. of Cardiology and Vascular Medicine of the Hannover Medical School, Germany and became a specialist for emergency medicine in 2018 and for internal medicine in 2019. In 2019, he started working at the Division of Cardiology, Vascular Medicine and Internal Intensive Care of the Mid-German Heart Center in Halle, Germany as an attending physician and clinician scientist. His research foci are vascular remodeling, acute cardiac care, palliative cardiac care, and medical ethics.

Empagliflozin impairs smooth muscle cell proliferation, accelerates endothelial regeneration, and prevents neointima formation by altered expression of the vasoactive peptide apelin

Event: ESC Congress 2020

Topic: Drugs, Drug Targets

Session: Basic Science Vascular ePosters

IL-6 production in the vascular adventitia and adventitia-media-crosstalk in neointima formation

Event: ESC Congress 2019

Topic: Leukocytes, Inflammation, Immunity

Session: Vascular inflammation

Adventitial interleukin-6 release is critical for neointima formation

Event: ESC Congress 2018

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Inflammation : vascular disease

BET bromodomain inhibition permits FoxO1-dependent cell cycle arrest in smooth muscle cells and prevents neointima formation

Event: ESC Congress 2018

Topic: Genetics, Epigenetics, ncRNA

Session: Best Posters in vascular disease pathogenesis

Adventitial interleukin-6 release is critical for neointima formation

Event: Frontiers in CardioVascular Biology 2018

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Session: Novel insights in signaling pathways in endothelial dysfunction

Adventitial cytokine production is critical for negative vascular remodelling

Event: ESC Congress 2017

Topic: Vascular remodelling

Session: Vascular remodelling

Adventitial activation is critical for negative vascular remodeling

Event: ESC Congress 2016

Topic: Vascular remodelling

Session: Vascular biology and remodelling

ESC 365 is supported by